Publicaciones en las que colabora con Mario David Cordero Morales (78)

2024

  1. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

    Antioxidants and Redox Signaling, Vol. 40, Núm. 13-15, pp. 751-758

  2. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

    Antioxidants and Redox Signaling, Vol. 41, Núm. 7-9, pp. 479-487

  3. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

    Journal of Berry Research, Vol. 14, Núm. 1, pp. 41-59

  4. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

    Inflammation Research, Vol. 73, Núm. 8, pp. 1253-1266

  5. The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

    Aging Cell, Vol. 23, Núm. 9

2021

  1. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria

    EMBO Molecular Medicine, Vol. 13, Núm. 10

  2. Inhibition of the NLRP3 inflammasome prevents ovarian aging

    Science Advances, Vol. 7, Núm. 1

  3. L-arginine ameliorates defective autophagy in gm2 gangliosidoses by mtor modulation

    Cells, Vol. 10, Núm. 11

2020

  1. Blockade of the NLRP3 inflammasome improves metabolic health and lifespan in obese mice

    GeroScience, Vol. 42, Núm. 2, pp. 715-725

  2. Is AMP-Activated Protein Kinase Associated to the Metabolic Changes in Primary Ovarian Insufficiency?

    Antioxidants and Redox Signaling, Vol. 33, Núm. 15, pp. 1115-1121

  3. NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 75, Núm. 8, pp. 1457-1464

  4. NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice

    Aging Cell, Vol. 19, Núm. 1

2018

  1. Autophagic dysfunction in patients with Papillon-Lefèvre syndrome is restored by recombinant cathepsin C treatment

    Journal of Allergy and Clinical Immunology, Vol. 142, Núm. 4, pp. 1131-1143.e7

  2. Gain of function mutation and inflammasome driven diseases in human and mouse models

    Journal of Autoimmunity, Vol. 91, pp. 13-22

  3. Inflammasomes in Clinical Practice: A Brief Introduction

    Experientia supplementum (2012), Vol. 108, pp. 1-8

  4. Intracellular cholesterol accumulation and coenzyme Q10 deficiency in Familial Hypercholesterolemia

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 12, pp. 3697-3713

2017

  1. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder

    Pharmacological Research, Vol. 121, pp. 114-121

  2. Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 5, pp. 269-275

  3. Inflammasome complex in health and disease: New pharmacological perspectives

    Current Drug Targets

  4. NLRP3 inflammasome: Common nexus between depression and cardiovascular diseases

    Nature Reviews Cardiology